About Index Trending news
Lists
Pricing
Savara Pharmaceuticals

Savara Pharmaceuticals

Savara Pharmaceuticals

Savara Pharmaceuticals develops an inhaled antibiotic for MRSA infection inCystic Fibrosis

Elsewhere

Alexa global traffic share

Latest funding Show all
Debt financing
$15,000,000
Venture capital (Series C)
$20,000,000
Employees

Team size

2
Locations
HQ
$15,000,000 Debt financing
texastechpulse

Savara Gets $15M In Debt Funding From SVB

Xconomy

Inhaled-Drug Maker Savara Buys European Biotech With Two Candidates

Health
$20,000,000 Venture capital (Series C)
FinSMEs , Xconomy

Savara Pharmaceuticals Closes $20M Series C Financing

Health Funding